The Key Pillars for Drug Discovery & Development Programs: Efficacy, Exposure, and Safety Assessment
Join us for an exclusive networking opportunity featuring insights from industry-leading experts in medical devices and surgical models! This seminar will provide a high-level overview of key considerations for drug discovery programs, including establishing a clear Target Product Profile and a fit-for-purpose testing funnel to efficiently obtain early signs of efficacy. Additionally, this seminar will cover how to integrate exposure analysis and creative safety assessment designs into a program for effectively making go/no-go decisions, as well as satisfying regulatory expectations.
Seminar Topics Include:
- How the critical pillars of a drug discovery program integrated with a well-defined Target Product Profile help enable informed go/no-go decisions.
- Strategies for effectively selecting the right preclinical model to assess disease pharmacology and improve translation to the clinic.
- Creatively designing your exploratory toxicology program for early de-risking.
- What the regulatory agencies expect from a comprehensive safety assessment package.
- Q&A and Consultation Session With Inotiv Scientists
This event is designed for professionals in life sciences, healthcare, and medical technology sectors looking to connect with peers, expand their network, and gain valuable knowledge about the latest advancements in medical devices and surgical models.
Questions: Contact Charlie Lawson, Charlie.lawson@inotiv.com and Kelly Hutchins, Kelly.hutchins@inotiv.com